Evidence map›Paper›PMID 39834817›Full record

ReviewFrontiers in pharmacology2024

An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.

Pratibha Pandey, Sorabh Lakhanpal, Danish Mahmood, Han Na Kang, Byunggyu Kim, Sojin Kang, Jinwon Choi, Min Choi, Shivam Pandey, Mahakshit Bhat and 4 more

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Process Optimization ofAntioxidants (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Antioxidants (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Crystal structure and Hirshfeld surface analysis of luteolin dimethyl sulfoxide monosolvate.Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  15. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  16. Antimetastatic Effects of aAntioxidants (Basel, Switzerland) · 2026
    Article
  17. Review
  18. Review
  19. Pleiotropic Effects of 3-International journal of molecular sciences · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pratibha PandeyCentre for Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.
Sorabh LakhanpalSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Danish MahmoodDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
Han Na KangKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Byunggyu KimDepartment of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Sojin KangDepartment of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Jinwon ChoiDepartment of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Min ChoiDepartment of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Shivam PandeySchool of Applied and Life Sciences, Uttaranchal University, Dehradun, India.
Mahakshit BhatDepartment of Medicine, National Institute of Medical Sciences, NIMS University Rajasthan, Jaipur, India.
Shilpa SharmaChandigarh Pharmacy College, Chandigarh Group of Colleges-Jhanjeri, Mohali, Punjab, India.
Fahad KhanCenter for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
Moon Nyeo ParkDepartment of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Bonglee KimKM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear factor-κB (NF-κB) cell signaling pathway is essential for the progression and development of numerous human disorders, including cancer. NF-κB signaling pathway regulates a wide range of physiological processes, such as cell survival, growth, and migration. Deregulated NF-kB signaling resulted in unregulated cell proliferation, viability, movement, and invasion, thus promoting tumor development. Recent findings have increasingly shown that plant derived phytochemicals that inhibit NF-κB signaling have the potential to be employed in cancer therapeutics. Flavonoids are a group of polyphenolic natural compounds present in various plants and their fruits, vegetables, and leaves. These compounds have numerous medicinal properties owing to their antioxidant, anti-inflammatory, antiviral, and antitumor characteristics. The main mechanism by which these flavonoids exhibit their anticancer potential is via potent antioxidative and immunomodulatory actions. Current research reports have demonstrated that these flavonoids exhibited their anticancer effects via suppressing the NF-κB signaling. Based on these facts, we have comprehensively outlined the cancer promoting role of NF-κB pathway in various processes including tumor progression, drug resistance, angiogenesis and metastasis. In addition to these, we also summarize the anticancer potential of flavonoids by specifically targeting the NF-κB pathway in various types of cancers.

Indexed as

anticancerflavonoidsnatural compoundsNF-kBsignaling/signaling pathways

Identifiers

PMID39834817
PMCPMC11743680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.